Correlation Between Replimune and NextCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Replimune and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and NextCure, you can compare the effects of market volatilities on Replimune and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and NextCure.

Diversification Opportunities for Replimune and NextCure

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Replimune and NextCure is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Replimune i.e., Replimune and NextCure go up and down completely randomly.

Pair Corralation between Replimune and NextCure

Given the investment horizon of 90 days Replimune Group is expected to generate 1.59 times more return on investment than NextCure. However, Replimune is 1.59 times more volatile than NextCure. It trades about 0.11 of its potential returns per unit of risk. NextCure is currently generating about -0.09 per unit of risk. If you would invest  1,028  in Replimune Group on September 2, 2024 and sell it today you would earn a total of  380.00  from holding Replimune Group or generate 36.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Replimune Group  vs.  NextCure

 Performance 
       Timeline  
Replimune Group 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Replimune and NextCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Replimune and NextCure

The main advantage of trading using opposite Replimune and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.
The idea behind Replimune Group and NextCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Technical Analysis
Check basic technical indicators and analysis based on most latest market data